H.B. 230 2nd Sub. (Gray)
2023/02/07 14:09, Lead Analyst: Russell T. Frandsen Attorney: CW1
Fiscal Note
H.B. 230 2nd Sub. (Gray)
2023 General Session
Center for Medical Cannabis Research
by Dailey-Provost, J. (Dailey-Provost,
Jennifer.)
General, Income Tax, and Uniform School Funds JR4-4-101
Ongoing One-time Total
Net GF/ITF/USF (rev.-exp.) $0 $0 $0
State Government UCA 36-12-13(2)(c)
Revenues FY 2023 FY 2024 FY 2025
Qualified Production Enterprise
Fund
$0 $2,500 $2,500
Total Revenues $0 $2,500 $2,500
Enactment of this legislation may increase ongoing revenue to the Qualified Production Enterprise
Fund by $2,500 beginning in FY 2024.
Expenditures FY 2023 FY 2024 FY 2025
Qualified Patient Enterprise Fund $0 $754,500 $754,500
Qualified Production Enterprise
Fund
$0 $2,500 $2,500
Total Expenditures $0 $757,000 $757,000
Enactment of this legislation may cost the University of Utah from the from the Qualified Production
Enterprise Fund $650,000 ongoing in FY 2024 to create the Center for the Medical Cannabis
Research. This funding includes paying the $2,500 annual cost beginning in FY 2024 for an academic
research cannabis license. Additionally, this legislation may cost the Department of Agriculture $2,500
ongoing from the Qualified Production Enterprise Fund beginning in FY 2024 for staff time to issue
an academic research cannabis license. Finally, this legislation may cost $104,500 ongoing for the
Department of Health and Human Services beginning in FY 2024 from the Qualified Patient Enterprise
Fund for staff to develop evidence-based guidance for treatment with medical cannabis.
FY 2023 FY 2024 FY 2025
Net All Funds $0 $(754,500) $(754,500)
Local Government UCA 36-12-13(2)(c)
Enactment of this legislation likely will not result in direct, measurable costs for local governments. H.B. 230 2nd Sub. (Gray)
2023/02/07 14:09, Lead Analyst: Russell T. Frandsen Attorney: CW1
Individuals & Businesses UCA 36-12-13(2)(c)
Enactment of this legislation likely will not result in direct expenditures from tax or fee changes for Utah
residents and businesses.
Regulatory Impact UCA 36-12-13(2)(d)
Enactment of this legislation likely will not change the regulatory burden for Utah residents or
businesses.
Performance Evaluation JR1-4-601
This bill does not create a new program or significantly expand an existing program.
Notes on Notes
Fiscal notes estimate the direct costs or revenues of enacting a bill. The Legislature uses them to balance the budget. They do not measure a bill's
benefits or non-fiscal impacts like opportunity costs, wait times, or inconvenience. A fiscal note is not an appropriation. The Legislature decides
appropriations separately.